The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress
Steve Schneible / aacr - At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cancers Initiative. Learn more about how this new Initiative will marshal global…
AI Summary: The AACR has unveiled a Rare Cancers Initiative to coordinate researchers, streamline data sharing, and speed therapeutic development for uncommon tumor types. By pooling expertise, funding and networks, the program seeks to overcome the chronic scarcity of trials and resources that leave rare‑cancer patients waiting for attention that’s been hard to come by.
DHS finalizes 4-year visa limit for international physician training
Paige Twenter / beckershospitalreview - On July 17, the Department of Homeland Security finalized a rule capping U.S. stays for international students and exchange visitors at four years, ending the open-ended “duration of status” framework for medical trainees. Here are six things to know: 1. …
AI Summary: The Department of Homeland Security finalized new visa policies that alter the duration and structure of certain training‑related visas for international physicians, decoupling program length from visa terms. The changes aim to tighten immigration controls while raising concerns about workforce planning and the pipeline of internationally trained clinicians in U.S. health systems.
Molina Healthcare plans more marketplace exits as ACA segment falters
fiercehealthcare - Molina Healthcare is planning further reductions in its marketplace business as high costs continue to pressure that segment, the company's top brass told investors on Thursday morning.
AI Summary: Molina Healthcare announced plans to withdraw from additional Affordable Care Act marketplaces, citing financial challenges and market pressures. The move signals growing instability for some insurers in the ACA exchange space and could limit options for consumers in affected regions, while reigniting debates about market design and access.
- Hospitals and employers feel squeeze as uninsured rates climb (4)
- Insurers retreat from ACA exchanges, sparking debate over causes (4)
Hospitals and employers feel squeeze as uninsured rates climb
Insurers retreat from ACA exchanges, sparking debate over causes
US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
medicalxpress - The Trump administration's disruptions to a global AIDS relief program have forced organizations to close clinics, lay off staff and cut services, seriously impeding efforts to prevent and treat the disease in dozens of countries, a new report released Tu…
AI Summary: A new analysis concludes recent U.S. policy shifts have weakened international HIV prevention and treatment initiatives, disrupting funding flows and partnership stability. Public health experts caution the changes could reverse progress in vulnerable regions, urging policymakers to recalibrate support to sustain global gains against HIV/AIDS.
D.C. appeals court sides with HHS in 340B drug discount program rebate challenge
fiercehealthcare - The ruling upheld a previous decision that pharma companies cannot impose rebates without HHS Secretary approval.
AI Summary: The D.C. appeals court sided with HHS in a legal challenge over 340B drug discount rebates, affirming federal authority over the program’s rebate models. The ruling preserves HHS policy changes that influence pricing and hospital participation, potentially reshaping pharmacy discounts and provider finances nationwide.
- Appeals court and federal rulings cement HHS 340B authority (3)
- CMS reimbursement shakeup: winners, losers and litigation fallout (3)
- HRSA’s revised 340B rebate pilot and oversight push (3)